{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:08:38Z","timestamp":1770962918827,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007787","name":"National Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002666","name":"Aalto University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of health","doi-asserted-by":"crossref","award":["R25GM067122"],"award-info":[{"award-number":["R25GM067122"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.bmcl.2018.01.043","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T06:43:10Z","timestamp":1517553790000},"page":"952-957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Design, synthesis, anti-inflammatory activity and molecular docking of potential novel antipyrine and pyrazolone analogs as cyclooxygenase enzyme (COX) inhibitors"],"prefix":"10.1016","volume":"28","author":[{"given":"Mardia T.","family":"El Sayed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa A.M.Sh.","family":"El-Sharief","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman S.","family":"Zarie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nesrin M.","family":"Morsy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed R.","family":"Elsheakh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrey","family":"Voronkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Berishvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghada S.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2018.01.043_h0005","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0006-2952(01)00747-X","article-title":"Dual inhibitors of cyclooxygenase and 5-lipoxygenase: A new avenue in anti-inflammatory therapy","volume":"62","author":"Fiorucci","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmcl.2018.01.043_h0010","first-page":"232","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2018.01.043_b0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0223-5234(01)01197-7","article-title":"Cyclooxygenase inhibitors\u2014current status and future prospects","volume":"36","author":"Dannhardt","year":"2001","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2018.01.043_b0015","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2174\/0929867024606678","article-title":"Heterocyclic compounds as inflammation inhibitors","volume":"9","author":"Sondhi","year":"2002","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmcl.2018.01.043_b0020","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2174\/0929867024606650","article-title":"Selective COX-2 inhibitors and dual acting anti-inflammatory drugs","volume":"9","author":"Bertolini","year":"2002","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmcl.2018.01.043_b0025","first-page":"114","article-title":"Design and synthesis of some enaminonitrile derivatives of antipyrine as potential novel anti-inflammatory and analgesic agents","volume":"3","author":"Fadda","year":"2015","journal-title":"J Biosci Med"},{"key":"10.1016\/j.bmcl.2018.01.043_b0030","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.bmc.2004.01.037","article-title":"Design, synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory-antimicrobial agents","volume":"12","author":"Bekhit","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2018.01.043_b0035","first-page":"2856","article-title":"The diverse pharmacological importance of pyrazolone derivatives","volume":"3","author":"Mariappan","year":"2010","journal-title":"J Pharm Res"},{"key":"10.1016\/j.bmcl.2018.01.043_b0040","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1067\/mai.2003.163","article-title":"IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone","volume":"111","author":"Himly","year":"2003","journal-title":"J Allergy Clin Imm"},{"key":"10.1016\/j.bmcl.2018.01.043_b0045","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.bbrc.2004.06.094","article-title":"A novel pyrazolone, 4,4-dichloro-1-(2,4-dichlorophenyl)-3-methyl-5-pyrazolone, as a potent catalytic inhibitor of human telomerase","volume":"320","author":"Kakiuchi","year":"2004","journal-title":"Biochem Biophys Res Comm"},{"key":"10.1016\/j.bmcl.2018.01.043_b0050","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/S0024-3205(02)01965-3","article-title":"Myocardial protection of MCI-186 in rabbit ischemia-reperfusion","volume":"71","author":"Wu","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/j.bmcl.2018.01.043_b0055","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1016\/j.bmcl.2005.08.040","article-title":"Synthesis and antidepressant activity of some 1,3,5-triphenyl-2-pyrazolines and 3-(2\u201d-hydroxy naphthalen-1\u201d-yl)-1,5-diphenyl-2-pyrazolines","volume":"15","author":"Prasad","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2018.01.043_h0065","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1039\/c1md00041a","article-title":"Edaravone containing isoindoline nitroxides for the potential treatment of cardiovascular ischaemia","volume":"2","author":"Walker","year":"2011","journal-title":"Med Chem Comm"},{"key":"10.1016\/j.bmcl.2018.01.043_h0070","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0022-3565(25)38652-0","article-title":"Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions","volume":"268","author":"Watanabe","year":"1994","journal-title":"J. Pharmaco. Exp. Therap."},{"key":"10.1016\/j.bmcl.2018.01.043_b0065","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0223-5234(00)90179-X","article-title":"Synthesis, characterization and pharmacological properties of some 4-arylhydrazono-2-pyrazoline-5-one derivatives obtained from heterocyclic amines","volume":"35","author":"Ku\u00e7ukguze","year":"2000","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2018.01.043_b0070","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/10426507.2010.505593","article-title":"A facile one-pot expeditious synthesis of thiazolyl-pyrazolones","volume":"186","author":"Venkata","year":"2011","journal-title":"Phosp Sulf Silic Rel Elem"},{"key":"10.1016\/j.bmcl.2018.01.043_b0075","first-page":"546","article-title":"Syntheses, characterization and evaluation of some 1,3,4-tri substituted-5-pyrazolone derivatives as dual anti-inflammatory and antimicrobial agents","volume":"3","author":"Vermaa","year":"2012","journal-title":"Der Pharm Sinica"},{"key":"10.1016\/j.bmcl.2018.01.043_b0080","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-111-27849","article-title":"Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs","volume":"111","author":"Winter","year":"1962","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.bmcl.2018.01.043_b0085","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4103\/0250-474X.26677","article-title":"Antiinflammatory activity of tenoxicam gel on Cerrageenan-Induced Paw oedema in rats","volume":"68","author":"Gupta","year":"2006","journal-title":"Ind J Pharm Sci"},{"key":"10.1016\/j.bmcl.2018.01.043_b0090","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Auto Dock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmcl.2018.01.043_b0100","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1248\/bpb.27.786","article-title":"Dual inhibition of cyclooxygenases-2 and 5-libooxgynase by deoxypodophyllotoxin (anthricin) in mouse bone marrow-derived mast cells","volume":"27","author":"Lee","year":"2004","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.bmcl.2018.01.043_b0105","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1016\/j.bmc.2011.06.019","article-title":"Analogue-based design, synthesis and molecular docking analysis of 2,3-diaryl quinazolinones as non-ulcerogenic anti-inflammatory agents","volume":"19","author":"Manivannan","year":"2011","journal-title":"Bioorg Med Chem"}],"updated-by":[{"DOI":"10.1016\/j.bmcl.2022.128626","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000}}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X18300520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X18300520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T12:49:15Z","timestamp":1751287755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X18300520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0960894X18300520"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2018.01.043","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, anti-inflammatory activity and molecular docking of potential novel antipyrine and pyrazolone analogs as cyclooxygenase enzyme (COX) inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2018.01.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}